Physician Assistant · Lafayette, CO
NPI
1215483649
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
280 Exempla Cir
Lafayette, CO, 80026
Phone (303) 338-4545
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$425K
1,406 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Tadgh Mander prescribed most often to Medicare patients was Insulin Glargine-Yfgn, with 243 prescriptions and refills. In total Tadgh Mander wrote 1,406 Medicare prescriptions that cost $425K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Insulin Glargine-Yfgn Generic | 243 | 585 | 92 | $28K |
| Humalog Insulin Lispro | 234 | 618 | 82 | $58K |
| Humalog Kwikpen U-100 Insulin Lispro | 81 | 205 | 38 | $29K |
| Ozempic Semaglutide | 80 | 83 | 16 | $59K |
| Humulin N Insulin Nph Human Isophane | 65 | 155 | 28 | $11K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 64 | 165 | 27 | $2,396 |
| Insulin Syringe Syring-Needl,disp,insul,0.3 Ml | 62 | 171 | 26 | $2,334 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 55 | 142 | 28 | $2,251 |
| Baqsimi Glucagon | 44 | 44 | 42 | $25K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 43 | 91 | 11 | $100K |
| Humulin R Insulin Regular, Human | 40 | 103 | 18 | $4,781 |
| Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 34 | 98 | 15 | $1,171 |
| Jardiance Empagliflozin | 34 | 102 | 13 | $17K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 32 | 48 | Under 11 | $27K |
| Levothyroxine Sodium Generic | 28 | 81 | 11 | $467 |
Brand drugs: 943 claims; generic drugs: 141 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tadgh Mander were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.